Endometriosis Associated with Inflammatory Bowel Disease

Home>
Specialties>
Gastroenterology>
Summary and Comment

Endometriosis Associated with Inflammatory Bowel Disease

Women with endometriosis had elevated risk for ulcerative colitis and Crohn disease, even more than 20 years after their diagnoses.

Endometriosis is the result of implantation of menstrual products from the endometrium that are not cleared by the immune system. To determine whether endometriosis is associated with inflammatory bowel disease (IBD) — also an autoimmune-related disorder — investigators in Denmark conducted a nationwide cohort study involving 37,661 women (mean age, 38.6 years) hospitalized with endometriosis during a 40-year period.

During >492,000 person-years of follow-up, the standardized incidence ratio was 1.5 for ulcerative colitis and 1.6 for Crohn disease. The risk for ulcerative colitis was highest among women diagnosed with endometriosis between the ages of 25 and 34. The risk for Crohn disease was highest among women diagnosed before age 25. The mean interval between endometriosis diagnosis and diagnosis of IBD was 10.8 years for ulcerative colitis and 9.8 years for Crohn disease. Risks for IBD remained elevated after >20 years of observation and were even higher when the analysis was confined to women with surgically verified endometriosis.

Comment: These data suggest a shared immunologic basis for endometriosis and IBD. Patients with endometriosis and clinical features associated with IBD should undergo gastrointestinal evaluation.

— Douglas K. Rex, MD

Published in Journal Watch Gastroenterology October 5, 2012

Citation(s):

Jess T et al. Increased risk of inflammatory bowel disease in women with endometriosis: A nationwide Danish cohort study. Gut 2012 Sep; 61:1279. (http://dx.doi.org/10.1136/gutjnl-2011-301095)

Original article (Subscription may be required)
Medline abstract (Free)

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. We ask that you keep your remarks to a reasonable length, and we reserve the right to withhold publication of remarks that do not meet this standard.

The editors of Journal Watch may respond to Reader Remarks, but we cannot promise to respond to a particular remark.

Remark subject:*

Your remark:*

Fields marked with an * are required.

Name as you'd like it to appear:
First & middle initial:*

Last:*

Email address (will not
be published):*

Professional specialty:*

Place of work (optional):

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

No competing interests

Or, the following competing interests (for example, financial stakes or professional relationships):

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.